Information Library

Results for: Phase II/III - Asia - P.R. China

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • DIA China

    Event — Conference Date(s): May 20 - May 23, 2012
    Location: Shanghai, China

  • BioPharma Asia 2012

    Event — Conference Date(s): March 19 - March 22, 2012
    Location: Singapore Marina Bay Sands

  • Quintiles Launches China CRO, Kun Tuo

    Press Release — December 13, 2011 – Further deepening its commitment to China, Quintiles announced the launch of Kun Tuo, a local contract research organization (CRO) built to service the unique needs of the Chinese biopharmaceutical industry and multinational biopharma companies operating in China.

  • Energizing Enrollment

    Case Study — October 4, 2011
    The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned.

  • Partnering is Key to Maximizing Rewards in Emerging Markets

    Press Release — September 27, 2011 – While biopharmaceutical spending in emerging markets is growing at double-digit rates – much faster than in developed nations – opportunities in “pharmerging” countries must be balanced with accompanying costs and risks of entering new markets.

  • New FDA Guidance on Antidiabetic Therapies

    White Paper — December 11, 2009
    Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. Learn what FDA cardiac safety requirements may mean for your development program.

  • Validated Biomarker Menu

    Brochure — July 14, 2009
    A comprehensive menu of validated cell, fluid and tissue based biomarker assays.

Page 1 of 1 (7 results)

Subscribe to Email Based on Your Interests

Set preferences